Citations (56)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Shoshana Barnoy, Hanan Gancz, Yuewei Zhu, Cary L. Honnold, Daniel V. Zurawski & Malabi M. Venkatesan. (2017) The Galleria mellonella larvae as an in vivo model for evaluation of Shigella virulence. Gut Microbes 8:4, pages 335-350.
Read now
Read now
Malabi M Venkatesan & Lillian L Van de Verg. (2015) Combination vaccines against diarrheal diseases. Human Vaccines & Immunotherapeutics 11:6, pages 1434-1448.
Read now
Read now
Ana Isabel Camacho, Juan Manuel Irache & Carlos Gamazo. (2013) Recent progress towards development of a Shigella vaccine. Expert Review of Vaccines 12:1, pages 43-55.
Read now
Read now
Robert W Kaminski & Edwin V Oaks. (2009) Inactivated and subunit vaccines to prevent shigellosis. Expert Review of Vaccines 8:12, pages 1693-1704.
Read now
Read now
Elżbieta Katarzyna Jagusztyn-Krynicka, Paweł Łaniewski & Agnieszka Wyszyńska. (2009) Update on Campylobacter jejuni vaccine development for preventing human campylobacteriosis. Expert Review of Vaccines 8:5, pages 625-645.
Read now
Read now
Articles from other publishers (51)
Robert K. M. Choy, A. Louis Bourgeois, Christian F. Ockenhouse, Richard I. Walker, Rebecca L. Sheets & Jorge Flores. (2022) Controlled Human Infection Models To Accelerate Vaccine Development. Clinical Microbiology Reviews 35:3.
Crossref
Crossref
Calman Alexander MacLennan, Stephanie Grow, Lyou-fu Ma & Andrew Duncan Steele. (2022) The Shigella Vaccines Pipeline. Vaccines 10:9, pages 1376.
Crossref
Crossref
SK Tousif AhamedNabanita Giri. (2021) Shigellosis and Development of Multiple Antimicrobial Resistance Mechanisms of Shigella spp.. Biosciences Biotechnology Research Asia 18:4, pages 703-718.
Crossref
Crossref
Malabi M. Venkatesan, Cassandra Ballou, Shoshana Barnoy, Monica McNeal, Jill El-Khorazaty, Robert Frenck & Shahida Baqar. (2021) Antibody in Lymphocyte Supernatant (ALS) responses after oral vaccination with live Shigella sonnei vaccine candidates WRSs2 and WRSs3 and correlation with serum antibodies, ASCs, fecal IgA and shedding. PLOS ONE 16:11, pages e0259361.
Crossref
Crossref
Richard Walker, Robert W. Kaminski, Chad Porter, Robert K. M. Choy, Jessica A. White, James M. Fleckenstein, Fred Cassels & Louis Bourgeois. (2021) Vaccines for Protecting Infants from Bacterial Causes of Diarrheal Disease. Microorganisms 9:7, pages 1382.
Crossref
Crossref
Ruklanthi de Alwis, Li Liang, Omid Taghavian, Emma Werner, Hao Chung The, Trang Nguyen Hoang Thu, Vu Thuy Duong, D. Huw Davies, Philip L. Felgner & Stephen Baker. (2021) The identification of novel immunogenic antigens as potential Shigella vaccine components. Genome Medicine 13:1.
Crossref
Crossref
Yrvin León, Lionel Zapata, Raúl E. Molina, Gaj Okanovič, Leonardo A. Gómez, Carla Daza-Castro, Manuel Flores-Concha, José L. Reyes & Angel A. Oñate. (2020) Intranasal Immunization of Mice with Multiepitope Chimeric Vaccine Candidate Based on Conserved Autotransporters SigA, Pic and Sap, Confers Protection against Shigella flexneri. Vaccines 8:4, pages 563.
Crossref
Crossref
Bakhos Jneid, Audrey Rouaix, Cécile Féraudet-Tarisse & Stéphanie Simon. (2020) SipD and IpaD induce a cross-protection against Shigella and Salmonella infections. PLOS Neglected Tropical Diseases 14:5, pages e0008326.
Crossref
Crossref
Yrvin León, Lionel Zapata, Alexis Salas-Burgos & Angel Oñate. (2020) In silico design of a vaccine candidate based on autotransporters and HSP against the causal agent of shigellosis, Shigella flexneri. Molecular Immunology 121, pages 47-58.
Crossref
Crossref
Marcela F. Pasetti, Malabi M. Venkatesan & Eileen M. Barry. 2020. Mucosal Vaccines. Mucosal Vaccines
515
536
.
Renee M. Laird, Zuchao Ma, Nelum Dorabawila, Brittany Pequegnat, Eman Omari, Yang Liu, Alexander C. Maue, Steven T. Poole, Milton Maciel, Kavyashree Satish, Christina L. Gariepy, Nina M. Schumack, Annette L. McVeigh, Frédéric Poly, Cheryl P. Ewing, Michael G. Prouty, Mario A. Monteiro, Stephen J. Savarino & Patricia Guerry. (2018) Evaluation of a conjugate vaccine platform against enterotoxigenic Escherichia coli (ETEC), Campylobacter jejuni and Shigella. Vaccine 36:45, pages 6695-6702.
Crossref
Crossref
M.S. Riddle, W.H. Chen, C.D. Kirkwood & C.A. MacLennan. (2018) Update on vaccines for enteric pathogens. Clinical Microbiology and Infection 24:10, pages 1039-1045.
Crossref
Crossref
Esther Ndungo, Arlo Randall, Tracy H. Hazen, Dane A. Kania, Krista Trappl-Kimmons, Xiaowu Liang, Eileen M. Barry, Karen L. Kotloff, Subhra Chakraborty, Sachin Mani, David A. Rasko & Marcela F. Pasetti. (2018)
A Novel
Shigella
Proteome Microarray Discriminates Targets of Human Antibody Reactivity following Oral Vaccination and Experimental Challenge
. mSphere 3:4.
Crossref
Crossref
Giulia Pilla & Christoph M. Tang. (2018) Going around in circles: virulence plasmids in enteric pathogens. Nature Reviews Microbiology 16:8, pages 484-495.
Crossref
Crossref
Robert W FrenckJr.Jr., Shahida Baqar, William Alexander, Michelle Dickey, Monica McNeal, Jill El-Khorazaty, Holly Baughman, Amy Hoeper, Shoshana Barnoy, Akamol E. Suvarnapunya, Robert W. Kaminski & Malabi M. Venkatesan. (2018) A Phase I trial to evaluate the safety and immunogenicity of WRSs2 and WRSs3; two live oral candidate vaccines against Shigella sonnei. Vaccine 36:32, pages 4880-4889.
Crossref
Crossref
Prabhurajeshwar C & Chandrakanth R. (2018) Shigellosis: A Conformity Review of the Microbiology, Pathogenesis and Epidemiology with Consequence for Prevention and Management issues. Journal of Pure and Applied Microbiology 12:1, pages 405-417.
Crossref
Crossref
Sapna Pahil, Neelam Taneja, Hifzur Rahman Ansari & G. P. S. Raghava. (2017) In silico analysis to identify vaccine candidates common to multiple serotypes of Shigella and evaluation of their immunogenicity. PLOS ONE 12:8, pages e0180505.
Crossref
Crossref
Mark S. Riddle, Robert W. Kaminski, Claudio Di Paolo, Chad K. Porter, Ramiro L. Gutierrez, Kristen A. Clarkson, Hailey E. Weerts, Christopher Duplessis, Amy Castellano, Cristina Alaimo, Kristopher Paolino, Robert Gormley & Veronica Gambillara Fonck. (2016) Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I Study. Clinical and Vaccine Immunology 23:12, pages 908-917.
Crossref
Crossref
Xiaolan Wang, Beibei Liu, Yafeng Dou, Hongjie Fan, Shaohui Wang, Tao Li, Chan Ding & Shengqing Yu. (2016)
The Riemerella anatipestifer
AS87_01735
Gene Encodes Nicotinamidase PncA, an Important Virulence Factor
. Applied and Environmental Microbiology 82:19, pages 5815-5823.
Crossref
Crossref
Sachin Mani, Thomas Wierzba & Richard I. Walker. (2016) Status of vaccine research and development for Shigella. Vaccine 34:26, pages 2887-2894.
Crossref
Crossref
D. Nag, H. Koley, R. Sinha, P. Mukherjee, C. Sarkar, J. H. Withey & R. Gachhui. (2016) Immunization of Mice with a Live Transconjugant Shigella Hybrid Strain Induced Th1 and Th17 Cell-Mediated Immune Responses and Confirmed Passive Protection Against Heterologous Shigellae. Scandinavian Journal of Immunology 83:2, pages 92-101.
Crossref
Crossref
Xinxin Zhao, Qing Liu, Jie Zhang, Yali Luo, Ying Luo, Qiong Liu, Pei Li & Qingke Kong. (2016) Identification of a gene in Riemerella anatipestifer CH-1 (B739-2187) that contributes to resistance to polymyxin B and evaluation of its mutant as a live attenuated vaccine. Microbial Pathogenesis 91, pages 99-106.
Crossref
Crossref
Christiane Gerke, Anna Maria Colucci, Carlo Giannelli, Silvia Sanzone, Claudia Giorgina Vitali, Luigi Sollai, Omar Rossi, Laura B. Martin, Jochen Auerbach, Vito Di Cioccio & Allan Saul. (2015) Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHB. PLOS ONE 10:8, pages e0134478.
Crossref
Crossref
Christoph F.R Hatz, Bettina Bally, Susanne Rohrer, Robert Steffen, Stefanie Kramme, Claire-Anne Siegrist, Michael Wacker, Cristina Alaimo & Veronica Gambillara Fonck. (2015) Safety and immunogenicity of a candidate bioconjugate vaccine against Shigella dysenteriae type 1 administered to healthy adults: A single blind, partially randomized Phase I study. Vaccine 33:36, pages 4594-4601.
Crossref
Crossref
Ajchara A. Vongsawan, Vinayak Kapatral, Benjamin Vaisvil, Henry Burd, Oralak Serichantalergs, Malabi M. Venkatesan & Carl J. Mason. (2015) The genome of Shigella dysenteriae strain Sd1617 comparison to representative strains in evaluating pathogenesis. FEMS Microbiology Letters 362:5.
Crossref
Crossref
Richard I. Walker. (2015) An assessment of enterotoxigenic Escherichia coli and Shigella vaccine candidates for infants and children. Vaccine 33:8, pages 954-965.
Crossref
Crossref
Prabhurajeshwar, Ajay kumar Oli, C Ashajyothi & R Kelmani Chandrakanth. (2015) Prevalence and antibiotic susceptibility pattern of fluoroquinolone resistant Shigella species isolated from infants stool in Gulbarga district, Karnataka, India. Asian Pacific Journal of Tropical Disease 5, pages S116-S120.
Crossref
Crossref
Barbara C. Gärtner & Tim Meyer. (2014) Vaccination in Elite Athletes. Sports Medicine 44:10, pages 1361-1376.
Crossref
Crossref
R. W. Kaminski, M. Wu, K. R. Turbyfill, K. Clarkson, B. Tai, A. L. Bourgeois, L. L. Van De Verg, R. I. Walker & E. V. Oaks. (2014) Development and Preclinical Evaluation of a Trivalent, Formalin-Inactivated Shigella Whole-Cell Vaccine. Clinical and Vaccine Immunology 21:3, pages 366-382.
Crossref
Crossref
Shannon J. Heine, Jovita Diaz-McNair, Abhay U. Andar, Cinthia B. Drachenberg, Lillian van de Verg, Richard Walker, Wendy L. Picking & Marcela F. Pasetti. (2014)
Intradermal Delivery of
Shigella
IpaB and IpaD Type III Secretion Proteins: Kinetics of Cell Recruitment and Antigen Uptake, Mucosal and Systemic Immunity, and Protection across Serotypes
. The Journal of Immunology 192:4, pages 1630-1640.
Crossref
Crossref
A.I. Camacho, J.M. Irache, J. de Souza, S. Sánchez-Gómez & C. Gamazo. (2013) Nanoparticle-based vaccine for mucosal protection against Shigella flexneri in mice. Vaccine 31:32, pages 3288-3294.
Crossref
Crossref
Shannon J. Heine, Jovita Diaz-McNair, Francisco J. Martinez-Becerra, Shyamal P. Choudhari, John D. Clements, Wendy L. Picking & Marcela F. Pasetti. (2013) Evaluation of immunogenicity and protective efficacy of orally delivered Shigella type III secretion system proteins IpaB and IpaD. Vaccine 31:28, pages 2919-2929.
Crossref
Crossref
Eileen M. Barry, Marcela F. Pasetti, Marcelo B. Sztein, Alessio Fasano, Karen L. Kotloff & Myron M. Levine. (2013) Progress and pitfalls in Shigella vaccine research. Nature Reviews Gastroenterology & Hepatology 10:4, pages 245-255.
Crossref
Crossref
Timothy J. Wells & Ian R. Henderson. 2013. Escherichia coli. Escherichia coli
499
532
.
Soma Mitra, Soumik Barman, Dhrubajyoti Nag, Ritam Sinha, Dhira Rani Saha & Hemanta Koley. (2012)
Outer membrane vesicles of
Shigella boydii
type 4 induce passive immunity in neonatal mice
. FEMS Immunology & Medical Microbiology 66:2, pages 240-250.
Crossref
Crossref
Ryan T. Ranallo, Suramya Fonseka, Tara L. Boren, Lisa A. Bedford, Robert W. Kaminski, Sejal Thakkar & Malabi M. Venkatesan. (2012) Two live attenuated Shigella flexneri 2a strains WRSf2G12 and WRSf2G15: A new combination of gene deletions for 2nd generation live attenuated vaccine candidates. Vaccine 30:34, pages 5159-5171.
Crossref
Crossref
Tao Wu, Christen Grassel, Myron M. Levine & Eileen M. Barry. (2011) Live Attenuated Shigella dysenteriae Type 1 Vaccine Strains Overexpressing Shiga Toxin B Subunit. Infection and Immunity 79:12, pages 4912-4922.
Crossref
Crossref
S. Barnoy, S. Baqar, R.W. Kaminski, T. Collins, K. Nemelka, T.L. Hale, R.T. Ranallo & M.M. Venkatesan. (2011) Shigella sonnei vaccine candidates WRSs2 and WRSs3 are as immunogenic as WRSS1, a clinically tested vaccine candidate, in a primate model of infection. Vaccine 29:37, pages 6371-6378.
Crossref
Crossref
Jae-Il LeeSang-Joon KimChung-Gyu Park. (2011)
Shigella flexneri
infection in a newly acquired rhesus macaque (
Macaca mulatta
)
. Laboratory Animal Research 27:4, pages 343.
Crossref
Crossref
François-Xavier Theillet, Catherine Simenel, Catherine Guerreiro, Armelle Phalipon, Laurence A Mulard & Muriel Delepierre. (2011) Effects of backbone substitutions on the conformational behavior of Shigella flexneri O-antigens: implications for vaccine strategy. Glycobiology 21:1, pages 109-121.
Crossref
Crossref
Yves Germani & Philippe J. Sansonetti. 2011. Replicating Vaccines. Replicating Vaccines
99
117
.
D. Tribble, R. Kaminski, J. Cantrell, M. Nelson, C. Porter, S. Baqar, C. Williams, R. Arora, J. Saunders, M. Ananthakrishnan, J. Sanders, G. Zaucha, R. Turbyfill & E. Oaks. (2010) Safety and immunogenicity of a Shigella flexneri 2a Invaplex 50 intranasal vaccine in adult volunteers. Vaccine 28:37, pages 6076-6085.
Crossref
Crossref
S. Barnoy, K.I. Jeong, R.F. Helm, A.E. Suvarnapunya, R.T. Ranallo, S. Tzipori & M.M. Venkatesan. (2010) Characterization of WRSs2 and WRSs3, new second-generation virG(icsA)-based Shigella sonnei vaccine candidates with the potential for reduced reactogenicity. Vaccine 28:6, pages 1642-1654.
Crossref
Crossref
Ryan T. Ranallo, Robert W. Kaminski, Tonia George, Alexis A. Kordis, Qing Chen, Kathleen Szabo & Malabi M. Venkatesan. (2010)
Virulence, Inflammatory Potential, and Adaptive Immunity Induced by
Shigella flexneri msbB
Mutants
. Infection and Immunity 78:1, pages 400-412.
Crossref
Crossref
Hemanta Koley, Soumik Barman, Nivedita Roy, Dhira Rani Saha & Ranajit Kumar. (2008) The efficacy and immunogenicity of a live transconjugant hybrid strain of Shigella dysenteriae type 1 in two animal models. World Journal of Microbiology and Biotechnology 25:4, pages 679-686.
Crossref
Crossref
Odile Launay, Christine Sadorge, Nathalie Jolly, Béatrice Poirier, Stéphane Béchet, Diane van der Vliet, Valérie Seffer, Nicola Fenner, Kelly Dowling, Raphaela Giemza, Julie Johnson, Anna Ndiaye, Muriel Vray, Philippe Sansonetti, Philippe Morand, Claire Poyart, David Lewis & Marie-Lise Gougeon. (2009) Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: Results of a Phase 2, randomized, double-blind placebo-controlled trial. Vaccine 27:8, pages 1184-1191.
Crossref
Crossref
Yin Mei Lim, Ad J. C. de Groof, Mrinal K. Bhattacharjee, David H. Figurski & Eric A. Schon. (2008) Bacterial Conjugation in the Cytoplasm of Mouse Cells. Infection and Immunity 76:11, pages 5110-5119.
Crossref
Crossref
Mi-Na Kweon. (2008) Shigellosis: the current status of vaccine development. Current Opinion in Infectious Diseases 21:3, pages 313-318.
Crossref
Crossref
David C. Pigott. (2008) Foodborne Illness. Emergency Medicine Clinics of North America 26:2, pages 475-497.
Crossref
Crossref
Gunnar N. Schroeder & Hubert Hilbi. (2008)
Molecular Pathogenesis of
Shigella
spp.: Controlling Host Cell Signaling, Invasion, and Death by Type III Secretion
. Clinical Microbiology Reviews 21:1, pages 134-156.
Crossref
Crossref
Ryan T. Ranallo, Sejal Thakkar, Qing Chen & Malabi M. Venkatesan. (2007) Immunogenicity and characterization of WRSF2G11: A second generation live attenuated Shigella flexneri 2a vaccine strain. Vaccine 25:12, pages 2269-2278.
Crossref
Crossref